| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 02:41:24 UTC |
|---|
| Update Date | 2022-11-30 19:25:54 UTC |
|---|
| HMDB ID | HMDB0114780 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(14:0/18:3(6Z,9Z,12Z)) |
|---|
| Description | PA(14:0/18:3(6Z,9Z,12Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:0/18:3(6Z,9Z,12Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of gamma-linolenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC InChI=1S/C35H63O8P/c1-3-5-7-9-11-13-15-16-17-18-20-22-24-26-28-30-35(37)43-33(32-42-44(38,39)40)31-41-34(36)29-27-25-23-21-19-14-12-10-8-6-4-2/h11,13,16-17,20,22,33H,3-10,12,14-15,18-19,21,23-32H2,1-2H3,(H2,38,39,40)/b13-11-,17-16-,22-20-/t33-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Myristoyl-2-gamma-linolenoyl-sn-glycero-3-phosphate | HMDB | | 1-Myristoyl-2-gamma-linolenoyl-sn-phosphatidic acid | HMDB | | PA(14:0/18:3) | HMDB | | PA(14:0/18:3N6) | HMDB | | PA(14:0/18:3W6) | HMDB | | PA(32:3) | HMDB | | Phosphatidic acid(14:0/18:3(6Z,9Z,12Z)) | HMDB | | Phosphatidic acid(14:0/18:3) | HMDB | | Phosphatidic acid(14:0/18:3n6) | HMDB | | Phosphatidic acid(14:0/18:3W6) | HMDB | | Phosphatidic acid(32:3) | HMDB | | Phosphatidate(14:0/18:3(6Z,9Z,12Z)) | HMDB | | Phosphatidate(14:0/18:3) | HMDB | | Phosphatidate(14:0/18:3N6) | HMDB | | Phosphatidate(14:0/18:3W6) | HMDB | | Phosphatidate(32:3) | HMDB | | 1-myristoyl-2-gamma-linolenoyl-sn-glycero-3-phosphate | SMPDB, HMDB | | 1-myristoyl-2-gamma-linolenoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(14:0/18:3) | SMPDB, HMDB | | PA(14:0/18:3n6) | SMPDB, HMDB | | PA(14:0/18:3w6) | SMPDB, HMDB | | PA(32:3) | SMPDB, HMDB | | Phosphatidic acid(14:0/18:3(6Z,9Z,12Z)) | SMPDB, HMDB | | Phosphatidic acid(14:0/18:3) | SMPDB, HMDB | | Phosphatidic acid(14:0/18:3n6) | SMPDB, HMDB | | Phosphatidic acid(14:0/18:3w6) | SMPDB, HMDB | | Phosphatidic acid(32:3) | SMPDB, HMDB | | Phosphatidate(14:0/18:3(6Z,9Z,12Z)) | SMPDB, HMDB | | Phosphatidate(14:0/18:3) | SMPDB, HMDB | | Phosphatidate(14:0/18:3n6) | SMPDB, HMDB | | Phosphatidate(14:0/18:3w6) | SMPDB, HMDB | | PA(14:0/18:3(6Z,9Z,12Z)) | SMPDB |
|
|---|
| Chemical Formula | C35H63O8P |
|---|
| Average Molecular Weight | 642.855 |
|---|
| Monoisotopic Molecular Weight | 642.426055987 |
|---|
| IUPAC Name | [(2R)-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]-3-(tetradecanoyloxy)propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]-3-(tetradecanoyloxy)propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC |
|---|
| InChI Identifier | InChI=1S/C35H63O8P/c1-3-5-7-9-11-13-15-16-17-18-20-22-24-26-28-30-35(37)43-33(32-42-44(38,39)40)31-41-34(36)29-27-25-23-21-19-14-12-10-8-6-4-2/h11,13,16-17,20,22,33H,3-10,12,14-15,18-19,21,23-32H2,1-2H3,(H2,38,39,40)/b13-11-,17-16-,22-20-/t33-/m1/s1 |
|---|
| InChI Key | QLVWNWHVOOSSFP-IVFLSWOASA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0064132)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/22:2(13Z,16Z)) (PathBank: SMP0064139)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0064140)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/24:1(15Z)) (PathBank: SMP0064145)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0072878)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/20:0) (PathBank: SMP0072880)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0072884)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0085557)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0088140)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/20:2(11Z,14Z)) (PathBank: SMP0088145)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0064135)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/22:1(13Z)) (PathBank: SMP0064138)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0064143)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/22:0) (PathBank: SMP0072888)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0072893)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/20:1(11Z)) (PathBank: SMP0064130)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0064141)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/24:0) (PathBank: SMP0072895)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0088142)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0064136)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/14:0) (PathBank: SMP0016626)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/15:0) (PathBank: SMP0016627)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/16:0) (PathBank: SMP0016628)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/18:0) (PathBank: SMP0016629)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/14:1(9Z)) (PathBank: SMP0016633)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/16:1(9Z)) (PathBank: SMP0016634)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/18:1(11Z)) (PathBank: SMP0016635)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/18:1(9Z)) (PathBank: SMP0016636)
- De Novo Triacylglycerol Biosynthesis TG(14:0/18:3(6Z,9Z,12Z)/18:2(9Z,12Z)) (PathBank: SMP0016641)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0083235)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0083236)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:0) (PathBank: SMP0083237)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0083238)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083239)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083240)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083241)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083242)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0083243)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0) (PathBank: SMP0083244)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0083245)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083246)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083247)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083248)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083249)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:0/20:0) (PathBank: SMP0083250)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:0/20:3(5Z,8Z,11Z)) (PathBank: SMP0083251)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:0/20:3(8Z,11Z,14Z)) (PathBank: SMP0083252)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083253)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083254)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083255)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0083256)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083257)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083258)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083259)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083260)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083261)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083262)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083263)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083264)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083265)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083266)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083267)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083268)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083269)
- Cardiolipin Biosynthesis CL(14:0/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083270)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 8.69 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 29.9812 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.97 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 4566.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 400.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 300.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 224.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 979.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1599.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1116.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 229.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3048.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1022.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2520.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1152.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 647.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 444.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 712.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(14:0/18:3(6Z,9Z,12Z)),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 4526.7 | Semi standard non polar | 33892256 | | PA(14:0/18:3(6Z,9Z,12Z)),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 4057.0 | Standard non polar | 33892256 | | PA(14:0/18:3(6Z,9Z,12Z)),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 5354.8 | Standard polar | 33892256 | | PA(14:0/18:3(6Z,9Z,12Z)),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4500.5 | Semi standard non polar | 33892256 | | PA(14:0/18:3(6Z,9Z,12Z)),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4038.0 | Standard non polar | 33892256 | | PA(14:0/18:3(6Z,9Z,12Z)),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4646.3 | Standard polar | 33892256 | | PA(14:0/18:3(6Z,9Z,12Z)),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4747.1 | Semi standard non polar | 33892256 | | PA(14:0/18:3(6Z,9Z,12Z)),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4166.8 | Standard non polar | 33892256 | | PA(14:0/18:3(6Z,9Z,12Z)),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 5339.0 | Standard polar | 33892256 | | PA(14:0/18:3(6Z,9Z,12Z)),2TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4951.6 | Semi standard non polar | 33892256 | | PA(14:0/18:3(6Z,9Z,12Z)),2TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4221.6 | Standard non polar | 33892256 | | PA(14:0/18:3(6Z,9Z,12Z)),2TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4706.0 | Standard polar | 33892256 |
|
|---|